Gastrointestinal hormones and bariatric surgery-induced weight loss

Obesity (Silver Spring). 2013 Jun;21(6):1093-103. doi: 10.1002/oby.20364.

Abstract

Obesity continues to be a major public health problem in the United States and worldwide. While recent statistics have demonstrated that obesity rates have begun to plateau, more severe classes of obesity are accelerating at a faster pace with important implications in regards to treatment. Bariatric surgery has a profound and durable effect on weight loss, being to date one of the most successful interventions for obesity.

Objective: To provide updates to the possible role of gut hormones in post bariatric surgery weight loss and weight loss maintenance.

Design and methods: The current review examines the changes in gastro-intestinal hormones with bariatric surgery and the potential mechanisms by which these changes could result in decreased weight and adiposity.

Results: The mechanism by which bariatric surgery results in body weight changes is incompletely elucidated, but it clearly goes beyond caloric restriction and malabsorption.

Conclusion: Changes in gastro-intestinal hormones, including increases in GLP-1, PYY, and oxyntomodulin, decreases in GIP and ghrelin, or the combined action of all these hormones might play a role in induction and long-term maintenance of weight loss.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Bariatric Surgery*
  • Bile Acids and Salts / metabolism
  • Caloric Restriction
  • Diabetes Mellitus, Type 2 / surgery
  • Gastrointestinal Hormones / metabolism*
  • Ghrelin / metabolism
  • Glucagon-Like Peptide 1 / metabolism
  • Humans
  • Obesity / surgery
  • Oxyntomodulin / metabolism
  • Peptide YY / metabolism
  • Postoperative Period
  • United States
  • Weight Loss*

Substances

  • Bile Acids and Salts
  • Gastrointestinal Hormones
  • Ghrelin
  • Oxyntomodulin
  • Peptide YY
  • Glucagon-Like Peptide 1